Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cancer Research|June 10, 2026
Circulating Cell-Free DNA Methylation Profiling Enables Detection, Distinction, and Estrogen Receptor Status Classification of Advanced Breast CancerSasha C Main, Mitchell J Elliott, Althaf Singhawansa, et al.
Nature Communications|March 19, 2022
Biomimetic hydrogel supports initiation and growth of patient-derived breast tumor organoidsElisabeth Prince, Jennifer Cruickshank, Wail Ba-Alawi, et al.
Therapeutic Advances in Medical Oncology|October 30, 2025
A retrospective analysis exploring the association of pretreatment neutrophil-to-lymphocyte ratio and immune checkpoint inhibitor outcomes in patients with advanced NSCLC and liver metastasesMaisam Makarem, Tuan Hoang, Mitchell J Elliott, et al.
Nature Communications|June 4, 2026
Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapyMitchell J Elliott, Jesús Fuentes-Antrás, Sasha C Main, et al.
Nature Communications|February 21, 2025
Longitudinal evaluation of circulating tumor DNA in patients undergoing neoadjuvant therapy for early breast cancer using a tumor-informed assayMitchell J Elliott, Philippe Echelard, Christodoulos Pipinikas, et al.
NPJ Precision Oncology|June 3, 2026
Longitudinal evaluation of serial ctDNA kinetics using joint modeling in patients with metastatic breast cancerChristopher Pretz, Jesús Fuentes-Antrás, Sasha Main, et al.
Science Advances|September 7, 2022
The spindle assembly checkpoint is a therapeutic vulnerability of CDK4/6 inhibitor-resistant ER<sup>+</sup> breast cancer with mitotic aberrationsIsabel Soria-Bretones, Kelsie L Thu, Jennifer Silvester, et al.
NPJ Breast Cancer|July 19, 2025
Personalized ctDNA monitoring in metastatic HR+/HER2- breast cancer patients during endocrine and CDK4/6 inhibitor therapyJesús Fuentes-Antrás, Mitchell J Elliott, Sasha C Main, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2025
Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast CancerMitchell J Elliott, Karen Howarth, Sasha Main, et al.
Cell Reports|October 17, 2023
Differential DNA damage repair and PARP inhibitor vulnerability of the mammary epithelial lineagesHyeyeon Kim, Kazeera Aliar, Pirashaanthy Tharmapalan, et al.
Pageof 2